Topical composition comprising clascoterone and latanoprost for alopecia

Abstract

The present invention relates to a topical pharmaceutical composition comprising approximately 0.001% w / w to approximately 1% w / w latanoprost and approximately 1% w / w to approximately 15% w / w cortexolone-17α-propionate, and a pharmaceutically acceptable vehicle comprising one or more solvents, and the process for preparing said composition. The invention further relates to the method wherein the composition is suitable for preventing and / or treating hair loss and / or stimulating hair growth in patients suffering from alopecia, particularly androgenic alopecia (AGA).